Advertisement
Australia markets open in 8 hours 17 minutes
  • ALL ORDS

    7,384.70
    -2.00 (-0.03%)
     
  • AUD/USD

    0.6578
    +0.0027 (+0.41%)
     
  • ASX 200

    7,173.30
    -5.10 (-0.07%)
     
  • OIL

    70.16
    +0.78 (+1.12%)
     
  • GOLD

    2,050.40
    +2.50 (+0.12%)
     
  • Bitcoin AUD

    66,002.73
    -873.51 (-1.31%)
     
  • CMC Crypto 200

    887.12
    -5.60 (-0.63%)
     

Why Voyager Therapeutics Stock Is Sinking This Week

Why Voyager Therapeutics Stock Is Sinking This Week

Shares of the gene therapy company Voyager Therapeutics (NASDAQ: VYGR) were down by a little over 18% from their intraweek high as of 11:44 a.m. ET Friday, according to data provided by S&P Global Market Intelligence. Rather, Voyager's shares seem to be reverting to the mean following their enormous run-up earlier this month. As a refresher, the biotech's shares spiked by as much as 76% during the first two weeks of January as a result of the company's lucrative gene therapy deal with Neurocrine Biosciences (NASDAQ: NBIX).